Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA PET/CT for Osseous Tumor Burden in mCRPC
NCT04951817Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2022
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Chang Gung Memorial Hospital. Primary endpoint: Positivity rate of Ga68-PSMA-11 PET-defined progression and Bone Scan-defined progression. Started Mar 2022; status: recruiting.
Beyond the preview
Go deeper on NCT04951817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951817.